Total Payments
$57,168
2024 Payments
$1,338
Companies
39
Transactions
513
Medicare Patients
9,053
Medicare Billing
$903,304
Payment Breakdown by Category
Other$37,223 (65.1%)
Consulting$11,581 (20.3%)
Food & Beverage$8,312 (14.5%)
Travel$28.15 (0.0%)
Education$24.89 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $37,223 | 30 | 65.1% |
| Consulting Fee | $11,581 | 18 | 20.3% |
| Food and Beverage | $8,312 | 460 | 14.5% |
| Travel and Lodging | $28.15 | 2 | 0.0% |
| Education | $24.89 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $25,635 | 148 | $0 (2024) |
| Mylan Specialty L.P. | $16,357 | 41 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $7,361 | 17 | $0 (2024) |
| Insmed, Inc. | $2,536 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,522 | 101 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $711.66 | 41 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $480.12 | 24 | $0 (2024) |
| Electromed, Inc. | $314.92 | 18 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $309.19 | 11 | $0 (2024) |
| Philips Electronics North America Corporation | $293.55 | 13 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,338 | 34 | Mylan Specialty L.P. ($534.00) |
| 2023 | $10,359 | 68 | GlaxoSmithKline, LLC. ($6,642) |
| 2022 | $10,816 | 56 | GlaxoSmithKline, LLC. ($5,343) |
| 2021 | $14,818 | 28 | GlaxoSmithKline, LLC. ($9,767) |
| 2020 | $13,093 | 37 | Harmony Biosciences LLC ($7,241) |
| 2019 | $4,078 | 108 | Insmed, Inc. ($2,378) |
| 2018 | $1,346 | 86 | GlaxoSmithKline, LLC. ($385.02) |
| 2017 | $1,321 | 96 | GlaxoSmithKline, LLC. ($422.60) |
All Payment Transactions
513 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $31.21 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $130.69 | General |
| Category: HFCWO | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: RESPIRATORY | ||||||
| 09/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Respiratory | ||||||
| 07/19/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $534.00 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/16/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Inflammation | ||||||
| 07/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Respiratory | ||||||
| 07/03/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Respiratory | ||||||
| 06/12/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $11.31 | General |
| Category: HFCWO | ||||||
| 05/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: RESPIRATORY | ||||||
| 05/22/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Pulmonology | ||||||
| 05/21/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: NEUROLOGY | ||||||
| 05/14/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Airway Clearance Device | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Respiratory | ||||||
| 05/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: RESPIRATORY | ||||||
| 05/01/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $23.89 | General |
| Category: Narcoplepsy | ||||||
| 04/03/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 2,062 | 2,700 | $381,165 | $190,655 |
| 2022 | 11 | 2,148 | 2,857 | $414,500 | $208,926 |
| 2021 | 13 | 2,342 | 3,135 | $452,130 | $237,846 |
| 2020 | 14 | 2,501 | 3,681 | $546,640 | $265,877 |
Total Patients
9,053
Total Services
12,373
Medicare Billing
$903,304
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 636 | 1,238 | $185,700 | $111,690 | 60.1% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 27 | 27 | $24,300 | $11,732 | 48.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 275 | 279 | $27,900 | $11,474 | 41.1% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 261 | 265 | $26,500 | $10,344 | 39.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 71 | 71 | $15,975 | $8,766 | 54.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 126 | 139 | $15,290 | $8,309 | 54.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 276 | 280 | $28,000 | $8,024 | 28.7% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 281 | 291 | $29,100 | $7,426 | 25.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 12 | 13 | $13,000 | $6,267 | 48.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 72 | 72 | $10,800 | $5,555 | 51.4% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 12 | 12 | $3,300 | $636.57 | 19.3% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 13 | 13 | $1,300 | $430.95 | 33.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 646 | 1,302 | $195,300 | $117,286 | 60.1% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 37 | 38 | $34,200 | $17,458 | 51.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 293 | 294 | $29,400 | $12,715 | 43.2% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 288 | 289 | $28,900 | $11,506 | 39.8% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 20 | 21 | $21,000 | $10,221 | 48.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 124 | 160 | $17,600 | $9,149 | 52.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 297 | 298 | $29,800 | $8,832 | 29.6% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 292 | 304 | $30,400 | $7,823 | 25.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 89 | 89 | $13,350 | $6,878 | 51.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 50 | 50 | $11,250 | $6,118 | 54.4% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2022 | 12 | 12 | $3,300 | $941.70 | 28.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 674 | 1,297 | $194,550 | $121,940 | 62.7% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Office | 2021 | 37 | 37 | $33,300 | $17,739 | 53.3% |
About Dr. Ivan Ackerman, M.D
Dr. Ivan Ackerman, M.D is a Pulmonary Disease healthcare provider based in Brandon, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609836089.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ivan Ackerman, M.D has received a total of $57,168 in payments from pharmaceutical and medical device companies, with $1,338 received in 2024. These payments were reported across 513 transactions from 39 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($37,223).
As a Medicare-enrolled provider, Ackerman has provided services to 9,053 Medicare beneficiaries, totaling 12,373 services with total Medicare billing of $903,304. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Brandon, FL
- Active Since 03/28/2006
- Last Updated 12/15/2009
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1609836089
Products in Payments
- TRELEGY ELLIPTA (Drug) $15,540
- Yupelri (Drug) $9,867
- Wakix (Drug) $7,291
- YUPELRI (Drug) $6,384
- Arikayce (Drug) $1,093
- SYMBICORT (Drug) $631.31
- OFEV (Drug) $461.94
- ANORO (Drug) $456.24
- GLASSIA (Biological) $342.15
- DUPIXENT (Biological) $336.06
- SMARTVEST (Device) $314.92
- BREZTRI (Drug) $247.56
- NUCALA (Biological) $221.95
- BREO (Drug) $208.61
- FASENRA (Drug) $197.62
- XYREM (Drug) $186.60
- Trilogy 100 (Device) $150.92
- ACTHAR (Biological) $148.77
- XYWAV (Drug) $144.74
- BEVESPI AEROSPHERE (Drug) $143.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Brandon
Dr. Daniel Lorch, M.d, M.D
Pulmonary Disease — Payments: $169,269
Pulmonary Disease $169,269
Dragos Zanchi, M.d, M.D
Pulmonary Disease — Payments: $45,595
Pulmonary Disease $45,595
Divyang Sorathia, M.d, M.D
Pulmonary Disease — Payments: $18,950
Pulmonary Disease $18,950
Dr. Arthur Graves, M.d, M.D
Pulmonary Disease — Payments: $4,613
Pulmonary Disease $4,613
Jonathan Axel, M.d, M.D
Pulmonary Disease — Payments: $1,644
Pulmonary Disease $1,644
Dr. Elizabeth Carpenter, Md, MD
Pulmonary Disease — Payments: $1,029
Pulmonary Disease $1,029